echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature: Spatial copy number analysis promises to distinguish benign from malignant tissue

    Nature: Spatial copy number analysis promises to distinguish benign from malignant tissue

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mutations can be inherited or acquired (somatic mutations)


    Recently, researchers from the Royal Institute of Technology in Sweden, the University of Oxford and other institutions have demonstrated that spatial analysis of copy number patterns in benign and malignant tissues can provide new insights into the clonal evolution of cancer


    Co-corresponding author Professor Joakim Lundeberg from the Royal Institute of Technology in Sweden said: "This high-resolution view helps us deal with complex ecosystems, such as cancer


    The research team first used prostate tissue as the analysis object and adopted a spatial transcriptomic strategy


    Using tens of thousands of regions in one patient's prostate tumor and nearby normal tissue, and as many as 120,000 tissue sample loci from more than 10 other individuals, they explored phylogenetic relationships between CNV-based clones


    "Tissue clonal diversity differs significantly across the five tissue types, while genomes ranging from homogeneous to highly heterogeneous are present in both tumor and benign tissue," the authors note, adding, "spatial information can help us identify morphologically indistinct of small clonal units, which would be overlooked by laser capture microdissection or even random sampling of single cells


    Notably, analysis of spatial loci showed that at least some of the cancer-related CNVs were also present in benign tissues of the same organ


    Through phylogenetic analysis, the research team went on to track the evolution of cancer-associated clones in benign and malignant tissues, narrowing down copy number losses and gains that appear to be hallmarks of ancestral clones and herald CNVs found in mature tumor samples cluster


    "Determining the transition from benign to malignant tissue is critical for improving early diagnosis of cancer," the authors explain, noting that the current findings "propose a model for how genomic instability can arise in benign tissue, which may represent an early event in cancer evolution


    Original text retrieval

    Erickson, A.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.